Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons Learned
ConclusionClinical trial recruitment for autoimmune encephalitis is challenging, and our trial did not meet recruitment goals. Large, multicenter clinical trials are still needed, and careful attention must be given to study design, endpoints, and patient selection. Instrumented functional rating scales will be valuable outcome measures for future studies.Trial RegistrationClinicalTrials.gov identifier: NCT03835728.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Brain | Clinical Trials | Encephalitis | Immunotherapy | Legislation | Lessons | Neurology | Study